Search

everythinglearnresearchcommunity

for

Search:↓

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Promising cancer treatments were found, but the manufacturer closed.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.